Periodic Reporting for period 1 - CAR-T-uning (Chimeric Antigen Receptor (CAR) T Cell Therapy For Solid Tumors)

Our research has provided valuable preclinical information on the enhanced therapeutic efficacy of NR2F6 gene-modified CAR-T cell therapies also for solid tumors. Indeed, the present ERC PoC 'CAR-T-uning' project research has validated the use of NR2F6-modified CAR-T, which...